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It	is	known,	that	most	behavioral	and	physiological	
functions,	including	immune	resistance,	are	expressed	
rhythmically	 across	days	 and	nights.	 These	daily	
rhythms	referred	to	as	circadian	provide	a	 temporal	
frame	 necessary	 for	 adequate	 homeostasis.	 CR	
enable	organisms	 to	adapt	 to	daily	 environmental	
changes	such	as	light,	temperature	etc.	and	serve	to	
synchronize	multiple	molecular	and	biochemical	pro-
cesses	with	each	other	[1–3].	A	number	of	pathologies	
are	accompanied	by	alteration	in	CR.	At	the	same	time,	
CR	discordance	can	lead	to	such	pathological	shifts	in	
organism	as	sleep	disorders,	cardiovascular	diseases,	
depression	and	so	on.	Recent	studies	show	the	con-
nection	between	altered	CR	and	cancer	 [4–6].	 It	 is	
established,	that	alteration	of	neuro-hormonal	circa-
dian	coordination	accelerates	the	growth	of	malignant	
tumors	in	mice	and	serves	a	poor	prognostic	factor	in	
cancer	patients	 [7–13],	 though	clinical	 relevance	of	
hormonal	CR	for	patients	outcome	may	differ	accord-
ing	to	the	hormonal	dependency	of	the	tumor	[14].
Immune	 system	 is	 involved	 in	 control	 of	 body	
homeostasis	and	 in	 the	 functional	 interaction	with	
nervous	and	endocrine	systems	[15–17],	but	chrono-
immunological	data	in	oncology	are	sparse.	It	is	known,	
that	some	tumors	are	associated	with	alterations	in	the	
host	CR	of	various	 lymphocyte	subsets	proportions	
and	probably	with	the	altered	circadian	dynamics	of	
immune	functions	[8,	9,	18].
Taking	into	account,	that	the	light	is	the	master	en-
vironmental	pacemaker,	controlling	circadian	dynam-
ics	of	all	physiological	parameters,	study	of	immune	
parameters	CR	in	patients	with	malignant	melanoma	
is	of	 the	special	 interest,	as	 the	 light	 radiation	and	
genetically	determined	alteration	in	skin	melanocytes	
photosensitivity	are	the	main	ethiologic	factors	of	this	
cancer.	In	addition,	human	malignant	melanoma	cells	
express	a	high-affinity	receptors	for	melatonin	—	the	
main	chronoimmunomodulator	[19,	20].
The	data	of	literature	concerning	CR	of	leucocytes	
cytotoxic	activity	 in	patients	with	malignant	melanoma	
are	lacking.	Obviously,	obtaining	such	data	would	be	of	
significant	interest.	At	the	same	time,	carrying	out	the	
chronobiological	 investigations	 in	oncology	 is	highly	
problematic.	It	requires	the	choice	of	special	methodic	
strategy	combining	,	on	the	one	hand,	maximal	sparing	
regimen	of	cell	collecting	(which	should	be	as	a	rule	done	
repeatedly	in	the	day-	and	night-time)	and,	on	the	other	
hand,	still	sufficient	informativeness	of	a	chosen	method	
as	to	immune	cells	activity	oscillations	during	24	h.	
Thus,	our	work	consisted	of	two	phases:	at	first,	an	
optimal	methodical	approach	was	elaborated	in	stud-
ies	with	healthy	donors,	and	only	then	the	melanoma	
patients	were	enlisted	to	the	investigation.
Materials and Methods
Blood sampling and cell isolation. CR	in	five	un-
treated	malignant	melanoma	patients	with	histologically	
proven	diagnosis	and	12	healthy	volunteers	were	inves-
tigated	according	to	the	following	protocol.	To	study	the	
rhythmicity	of	cell	cytotoxic	activity,	the	blood	samples	
were	taken	at	9	a.m.,	13	p.m.,	17	p.m.,	21	p.m.,	1	a.m.	
and	5	a.m.,	effector	cells	were	isolated	immediately	and	
NK-cell	 lytic	activity	and	phagosyte	cytotoxic	activity 
were	examined.	This	methodical	approach	hereafter	
is	referred	to	as	an	“in vivo method”.To	study	the	abil-
ity	of	cells	to	preserve		circadian	rhythmicity	in	vitro,	a	
portion	of	blood	was	taken	once	at	9	a.m.	and	kept	in	
darkness	at	20	°C.	The	samples	for	leucocytes	isolation	
and	rhythm	testing	were	taken	from	this	portion	at	the	
same	six	time	points	(the	methodical	modification	was	
designated	an	“in vitro	method”).
CirCadian rhYthMs oF CYtotoXiC aCtiVitY 
in PeriPheral Blood MononUClear Cells oF Patients 
With MaliGnant MelanoMa
N.F. Gamaleia1, L.M. Skivka2,*, A.G. Fedorchuk1, E.D. Shishko1
1Institute for Experimental Pathology, Oncology and Radiobiology NAS of Ukraine, Kyiv, Ukraine
2Kyiv National University, Kyiv, Ukraine
Aim: To study circadian rhythms (CR) of cytotoxic activity in peripheral blood mononuclear cells of patients with malignant melanoma 
were compared with those in healthy men. Methods: The NK-cell and phagocyte cytotoxic activity in five patients with malignant mela-
noma stage I or II and 12 healthy donors has been assessed by radioimmune assay and NBT-test. Results: The circadian rhythmicity in 
NK-cells and phagocyte activity in all cancer patients under study has been disrupted. The extent of such disruption tended to increase 
in patients with more advanced cancer. The most typical alterations were discoordination between the cytotoxicity rhythms of NK-cells 
and phagocytes (synchronized in healthy persons) and alterations in basic rhythm parameters: phase shifts and amplitude damping. 
Conclusion: In melanoma patients the significant alteration of CR in NK-cells and phagocytes cytotoxic activity was revealed. In spite 
of individual variations, the degree of the rhythm disruption basically depended on a disease stage. The alteration of CR phase and 
amplitude and discoordination between the rhythms of NK- cells and phagocyte were registered in all cases studied.
Key Words: malignant melanoma, circadian rhythm, NK-cell activity, phagocytes cytotoxic activity. 
Received: October 12, 2005. 
*Correspondence: E-mail: realmed@i.com.ua 
Abbreviations used: PBMC — peripheral blood mononuclear cells; 
NK-cell — natural killer cells; CR — circadian rhythms; NBT — nitro-
blue-tetrasolium.
Exp	Oncol	2006
28,	1,	54–60
Experimental	Oncology	28,	54–60,	2006	(March)	 55
To	 avoid	 the	 circannual	 alteration	of	 circadian	
rhythms,	all	presented	experiments	were	carried	out	
in	the	same	season	(in	summer).
Mononuclear	cells	were	isolated	from	heparinized	
blood	by	centrifugation	 in	 ficoll-verografin	gradient	
(ρ	=	1,077).
The	investigations	were	approved	by	Institute	Ethic	
Committee.
NK-cell cytoxicity assay.	NK-cell	cytotoxic	ac-
tivity	of	PBMC	was	tested	in	a	4	h		51Cr-release	assay	
[21,	22].	The	assay	was	performed	using	RPMI-1640	
medium	with	10%	heat-inactivated	FCS,	2	mM	L-glu-
tamine,	50U/ml	penicillin	and	50µg/ml	streptomycin	
(Sigma,	Germany).	As	a	 target	cells	erythromyeloid	
cell	line	K-562,	labeled	with	51Cr,	were	used.	A	mixture	
of	effector	and	target	cells	(25	:	1)	was	 incubated	 in	
U-bottomed	96-well	plates	(Lenmedpolimer,	Russia)	
in	CO2	incubator	at	37	
°C.	The	isotope	maximal	release	
and	spontaneous	release	were	determined	by	treatment	
of	the	target	cells	with	detergents	or	medium	respec-
tively.	All	determinations	were	made	in	quadruplicates.	
Radioactivity	was	counted	in	a	gamma	counter	(Compu-
gamma,	Sweden),	and	percentage	of	target-cell	lysis	
was	determined	according	to	the	formula:
Target cell lysis (%) =   Me – Ms   x 100, 
                          Mmax — Ms
where: Me — mean cpm experimental release; Ms — mean cpm spontane-
ous release; Mmax — mean cpm maximal release.
Determination of fagocyte cytotoxic activity.	
Total	leucocyte	phagocytic	actyvity	was	assessed	either	
with	isolated	leucocytes	[23]	or	with	a	whole	blood	[24]	
by	method	of	nitroblue-tetrasolium	(NBT)	reduction.	Pir-
rogenal	solution	was	used	to	stimulate	the	cell	oxidative	
burst.	The	optical	density	of	diformazane	formed	was	
measured	by	spectrophotometer	(Specoll,	Germany)	
and	microplatephotometer	(Labotec,	Latvia)	(λ	=	630	
nm).	NBT	reduction	index	(k)	was	determined	according	
to	the	formula:
k (%) = ODsc – ODcc x 100, 
ODcc
where:	ODsc	—	optical	density	of	stimulated	cells;	
ODcc	—	optical	density	of	control	cells.
Statistical analyses.	 Statistical	 analysis	was	
performed	using	cosinor	method,	special	mathematic	
method,	developed	 for	biological	 rhythms	analysis	
[25],	 linear	correlation	coefficient	and	variation	sta-
tistic	methods	[26].
resUlts and disCUssion
The	first	phase	of	the	work	consisted	in	comparison	of	
cell	cytotoxicity	assayed	by	two	methods	(“in vitro”	and	“in 
vivo”)	simultaneously.	These	experiments	were	carried	out	
only	with	healthy	volunteers.	Their	aim	was	to	ascertain	the	
possibility	to	substitute,	in	studies	with	melanoma	patients,	
one	blood	collection	procedure	for	six	such	procedures	
(necessary	for	analysis	of	a	daily	rhythm).	
The	substitution	would	be	acceptable	if	it	turned	out	
that	leucocytes	retained	the	rhythmic	character	of	their	
cytotoxicity	in	a	portion	of	blood	kept	for	24	h	under	 in 
vitro	conditions.	The	maintenance	of	the	same	rhythmicity	
in	cytotoxicity	in	a	blood	sample	kept	for	24	h	in vitro	was	
regarded	as	criterion	of	acceptance	for	substitution	stated	
above	(as	it	was	shown	earlier	for	CR	of	T-lymphocytes		ro-
sette-forming	activity	[27,	28]).	Then,	one	portion	of	blood	
collected,	for	example,	at	9	a.m.	could	serve	as	a	source	
of	cells	for	testing	their	activity	at	all	other	time	points.
PBMC	isolated	from	healthy	donors	showed	significant	
two-phase	CR	of	NK-cell	lytic	activity	both	under	condi-
tions	“in vivo”	and	“in vitro”	(Fig.	1).	Patterns	of	the	cytolytic	
activity	rhythms	obtained	by	these	two	methods	were	quite	
similar.	It	is	still	necessary	to	point	out,	that	the	target-cells	
lysis	indices	under	”in vitro	method”	were	at	the	every	time	
point	5–7%	lower	than	corresponding	indices	under	“in 
vivo method”.	In	both	variants	of	experiments,	the	highest	
day	time	level	of	NK-cell	cytolitic	activity	was	at	13	p.m.	
and	the	highest	night-time	level	—	at	1	a.m.	(In	Fig.1–4	
the	main	circadian	characteristics	—	acrophase,	mesor,	
amplitude,	were	calculated	by	single	cosinor	method	(data	
not	shown)).	The	average	daily	index	(mesor)	was	34.6%	
in	“in vivo”	tests	and	28.3	%	in	tests	“in vitro”.		Circadian	
fluctuations	in	the	amplitude	of	cytolitic	activity	were	insig-
nificantly	lower	“in vitro”	than	“in vivo”.
Fig. 1. CR	of	healthy	volunteers’	(n	=	12)	NK-cell	activity	tested	
by	methods	“in vivo”	(thick	line)	and	“in vitro”	(thin	line)
Comparison	of	circadian	variations	in		total	leucocyte	
phagocytic	activity	“in vitro”	and	“in vivo”	also	demonstrat-
ed	their	similarity	(Fig.	2).	As	with	the	activity	of	NK-cells,	
phagocytes	showed	two-phase	circadian	rhythms	of	their	
cytotoxicity,	both	“in vitro”	and	“in vivo”.	Again,	the	day-
time	highest	level	of	the	activity	was	about	13	p.m.	and	the	
night-time	highest	level	—	about	1	a.m.	Mesor		values	were	
124%	“in vivo”	and	113%	“in vitro”.	In	average,	cytotoxic	
activity	coefficients	of	mononuclear	phagocytes	isolated	
from	freshly	taken	blood	samples	were	5%	higher	than	
in	cells	obtained	from	single	deposited	portion	of	blood.	
Finally,	CR	amplitude	of	the	phagocyte	cytotoxic	activity	
did	not	differ	in	tests	“in vitro”	and	“in vivo”.
Thus,	it	may	be	concluded	that	the	“in vitro	method”	
of	determination	of	total	leucocyte	phagocytic	and	NK-
cells	cytotoxic	activity	of	PBMC	reproduces	rather	closely	
main	characteristics	of	the	rhythms,	obtained	in	healthy	
donors	under	conditions	“in vivo”.	Evaluation	of	the	sta-
tistic	connection	of		parameters	found	“in vitro”	and	“in 
vivo”	using	linear	correlation	coefficient	(r)	confirmed	this	
conclusion:	for	NK-cell	cytotoxicity	r =	0.38	(P < 0.01)	and	
for	total	leucocyte	cytotoxicity	r =	0.34	(P < 0.01).	
The	aim	of	next	experiments	was	to	find	out	whether	
the	micro	modified	methods	will	be	sensitive	enough	
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to	register	small	fluctuations	in	the	cytotoxic	activity	
level	caused	by	CR.
 
Fig. 2. Circadian	rhythms	of	healthy	volunteers’	(n	=	12)	phago-
cyte	cytotoxicity	tested	“in vivo”	(thick	line)	and	“in vitro” (thin	
line).	k*	—	NBT	reduction	index
Circadian	patterns	of	NK-cell	cytolytic	activity	obtained	
with	the	isolated	PMBC	and	whole	blood	(	see	Fig.	3)	were	
of	the	same	type	although	the	values	for	a	whole	blood	
were	on	the	average	1.4	times	lower,	than	in	tests	with	
isolated	mononuclear	cells.	But	the	statistical	analysis	
(linear	correlation	coefficient	r =	0.57,	P < 0.01)	shows	a	
high	degree	of	comparability	between	obtained	results.
Fig. 3. CR	of	healthy	volunteers’	(n	=	7)	NK-cell	activity	obtained	
with	isolated	PBMC	(macro-method,	thin	line)	and	a	whole	blood	
(micro-method,	thick	line)	
Similarly,	comparison	of	daily	rhythms	of	phagocyte	
activity	in	a	whole	blood	and	isolated	leucocytes	re-
vealed	their	practical	identity	(r =	0.69,	p < 0.05)	(	see	
Fig.	4),	though,	again		absolute	values	of	stimulation	
indices	for	 isolated	 leucocytes	were	on	the	average	
1.5	times		higher	than	in	tests	with	a	whole	blood.
Fig. 4. CR	of	healthy	 vounteers’	 (n	=	7)	cytotoxic	activity	 in	
isolated	leucocytes	(macro-method,	thin	line)		and	whole	blood	
(micro-method,	thick	line	k*	—	NBT	reduction	index.
Summerazing,	the	results	of	this	preparative	stage	of	
work	enabled	us	subsequently	to	study	CR	of	malignant	
melanoma	patients	by	methods	“in vitro”	in	their	micro	
modifications,	its	with	the	use	of	a	patient’s	whole	blood.	
And	what	is	more,	preservation	by	leucocytes	the	CR	of	
their	cytotoxic	activity	in vitro,	at	least	for	24	h,	confirms	
presence	 in	human	 lymphoid	cells	of	self-sustained	
circadian	clock,	as	we	have	suggested	earlier	[27].
Circadian rhythms of NK-cell cytotoxic activity 
in melanoma patients. It	was	established	that	daily	
rhythms	of	NK-cell	cytotoxicity	in	patients	with	malig-
nant	melanoma	differed	significantly	from	the	rhythm	
of	healthy	volunteers	(Fig.	5).	The	most	typical	distinc-
tive	features	of	circadian	profiles	in	the	patients	were	
the	shifts	in	a	position	of	time	points	of	NK-cell	activity	
maxima	and	minima	and	amplitude	changes.	A	degree	
of	 the	alterations	depended	on	the	disease	stage.	 In	
one	patient	with	the	stage	T1,	residual	features	of	the	
two-phase	donor-type	rhythm	were	still	preserved	(Fig.	
5.1,	Table	1,	1).	In	two	other	patients	with	this	stage	of	
the	tumor	growth	(Fig.	5.2.	and	5.3.,	Table	1.2	and	1.3),	
twofold	reduction	of	the	rhythm	amplitude	in	compari-
son	with	healthy	persons	and	partial	displacement	of	
minimum	and	maximum	time	points	were	observed.	
Daily	average	values	in	patients	with	disease	stage	T1	
were	1.3	time	lower	than	in	healthy	donors.
From	the	example	of	two	patients	with	stage	T2	it	is	
apparent	that,	depending	on	the	disease	progress,	more	
significant	modifications	in	circadian	profiles	of	NK-cell	
cytotoxic	activity	occurred	with	simultaneous	amplitude	
recovering	(Fig.	5.4.	and	5.5,	Table	1.4	and	1.5).	In	one	
of	the	patients,	a	full	inversion	of	NK-cells	activity	circa-
dian	curve	was	observed	in	comparison	with	the	normal	
rhythm	(Fig.	5.4,	Table	1.4).	It	is	interesting	that	similar	
inversion	in	daily	rhythms	of	NK-cells	and	total	leucocytes	
cytotoxic	activity	of	healthy	donors	we	found	earlier	when	
comparing	the	rhythms	during	two	different	seasons:	in	
summer	time	and	winter	time	[29].
In	 other	 patient	with	melanoma	 T2	 (Fig.	 5.5.,	
Table	1.5),	 the	 loss	of	 two-phase	rhythm	periodicity	
was	evident	in	consequence	of	which	the	rhythm	as-
sumed	one-phase	character.	 	Both	patients	of	 this	
group	had	amplitude	of	NK-cell	activity	daily	oscillations	
higher	than	in	patients	with	stage	T1	approximating	to	
the	donor	values.	Moreover,	the	average	daily	values	
of	NK-cell	 cytotoxic	activity	 in	 these	patients	were	
1.5–2.0	times	higher	than	in	healthy	donors.	It	seems	
that	rhythm	structure	simplification	in	the	patients	was	
compensated	by	amplitude	augmentation.
Thus,	significant	alterations	in	CR	of	NK-cell	activity	
occurred	in	all	of	the	patients	with	malignant	melanoma	
studied.	The	similar	modifications	in	CR	of	immune	cell	
functions	were	described	by	Akbulut	H.	et	al.	[30]	in	
patients	with	breast	cancer	and	by	Raida	M.	et	al.	[31]	
in	patients	with	advanced	gastrointestinal	carcinomas.	
In	patients	with	breast	cancer,	the	alterations	in	CR	of	
immune	cells	correlated	with	those	in	daily	dynamics	
of	melatonine	levels	and,	partly,	with	cortisole	levels.	In	
patients	with	gastrointestinal	carcinomas,	the	precise	
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correlation	between	the	hormonal	CR	and	immune	cell	
activity	circadian	dynamics	was	absent.
Table 1. Circadian characteristics of rhythms in Fig. 5 evaluated by single 
cosinor method
Patient T category Time of day Mesor Amplitude Acrophase
1 T1 Day time 17.4 6.6 193° (12 : 52)Night 14.8 6.1 3° (11 : 25)
2 T1 Day time 13.6 4.8 171° (11 : 25)Night 16.6 6.1 2° (0 : 10)
3 T1 Day time 28.6 10.0 199° (13 : 19)Night 28.6 9.2 9° (0 : 38)
4 T2 Day time 34.6 10.2 212° (14 : 09)Night 51.8 14.6 26° (1 : 45)
5 T2 Day time 38.2 9.6 171° (11 : 25)Night 46.6 10.9 2° (0 : 10)
Circadian rhythms of phagocytes cytotoxic 
activity in melanoma patients. As	indicated	above,	
in	healthy	donors	the	CR	of	total	cytotoxic	activity	of	
leucocytes	completely	coinsides	with	that	of	NK-cells	
(see	Fig.	3,	4):	it	has	the	same	two-phase	character	
with	peaks	at	13	p.m.	and	1	a.m.	(acrophase	at	13	p.m.)	
and	with	troughs	at	17	p.m.	and	5	a.m.	
The	CR	of	phagocytes	cytotoxic	activity	in	melanoma	
patients	has	obvious	distinctions.	The	most	typical	for	
patients	with	T1	stage	(Fig.	6.1–6.3.,	Table	2.1–2.3)	
was	amplitude	damping:	the	amplitude	of	phagocytes	
activity	circadian	oscillations	in	these	patients	was,	on	
the	average,	30%	lower	than	in	healthy	donors.	How-
ever,	average	daily	level	of	phagocyte	cytotoxic	activity	
in	patients	with	this	stage	was	equal	to	maximum	level	
in	healthy	donors	or	even	above	it.	Additionally,	phase	
deviations	were	evident	in	the	rhythms	of	these	patients.	
In	two	of	them	(Fig.	6.1.,	6.3,	Table	2.1,	2.3),	poorly	ex-
pressed	single-phase	rhythm	was	observed,	and	one	of	
the	patients	(Fig.	6.1.,	Table	2.1)	had	this	only	preserved	
peak	near	17	p.m.	(i.e.,	at	the	time	when	PBMC	from	
healthy	donors	exhibit	minimum	of	cytotoxic	activity).	
As	far	as	it	is	possible	to	judge	from	only	two	cases	
included	in	this	investigation	the	main	charateristic	fea-
ture	of	CR	in	the	cytotoxicity	of	melanoma	patients	with	
T2	stage	(Fig.6.4,	6.5,	Table	2.4,	2.5)	was	amplitude	aug-
mentation	(comparing	to	patients	with	T1	stage)	against	
the	background	of	general	rhythm	simplification,	i.e.	the	
changes	were	similar	to	such	for	NK-cells	activity.
Table 2. Circadian characteristics of rhythms in Fig. 6 evaluated by single 
cosinor method
Patient T category Time of day Mesor Amplitude Acrophase
1 T1 Day time 105.2 31.8 199° (13 : 16)Night 101.2 28.0 15° (1 : 20)
2 T1 Day time 102.4 35.2 196° (13 : 07)Night 106.4 31.2 9° (0 : 37)
3 T1 Day time 132.2 28.7 192° (12 : 51)Night 122.0 21.2 13° (0 : 55)
4 T2 Day time 99.4 32.2 204° (13 : 38)Night 29.8 10.4 7° (0 : 29)
5 T2 Day time 184.2 70.3 193° (12 : 54)Night 125.4 48.8 2° (23 : 49)
Analysing	melanoma	patients’	rhythms	of	phago-
cytes	and	NK	cells	cytotoxic	activity	in	parallels	(see	
Fig.	5,	6),	it	is	clear	that	synchronism	of	the	rhythms	
between	these	two	leucocyte	subpopulations	which	
is	characteristic	for	healthy	donors	(Fig.	1–4)	is	com-
pletely	lost	in	all	of	the	patients.
Thus,	 in	 the	present	study	 it	 is	shown	for	 the	first	
time	that	in	patients	with	a	primary	untreated	melanoma	
deep	alterations	 in	circadian	rhythms	of	NK-cell	and	
total	leucocyte	phagocytic	activity	occur.	The	separate	
preparatory	part	of	the	work	was	designed	to	choose	
and	approbate	in	chronobiological	experiments	more	
sparing	and	less	damaging	methodical	approaches	that	
allowed	to	realize	such	serial	24	hr-long	investigations,	
at	least	on	the	restricted	group	of	cancer	patients.
In	spite	of	small	number	of	the	melanoma	patients	
examined,	 the	general	 conclusion	about	dramatic	
changes	in	cytotoxic	activity	rhythms	with	alteration	of	
all	principal	circadian	parameters	and	loss	of	synchro-
nism	between	rhythms	of	NK-cells	and	phagocytes	is	
deemed	rather	 founded	because	 the	changes	were	
apparent	in	all	five	patients.	Unlike	that,	observations	
as	to	peculiarities	of	the	rhythm	deterioration	depend-
ing	on	disease	stage	1	or	2	are	purely	tentative	being	
based	on	a	comparison	of	groups	with	only	three	and	
two	patients,	correspondingly.
Mechanisms	of	alteration	 in	CR	of	 lymphoid	cell	
functions	are	difficult	to	explain.	There	are	attempts	to	
link	such	alterations	with	an	endocrine	system	dysfunc-
tion.	Data	of	human	and	animal	studies	suggest	that	in	
a	healthy	organism	both	immune	cell	subpopulations	
number	and	activity	exhibit	CR	that	seem	to	correlate	
with	daily	fluctuations	of	the	cortisol	level	[15,	16].	But	in	
cancer	patients	the	alteration	of	this	cortisol	rhythmicity	
is	observed	only	when	tumors	are	hormone	dependent	
[14,	31].	It	is	also	known	that	secretion	of	melatonin	is	
disturbed	in	patients	with	some	tumors	[33,	34].	Based	
on	these	results,	some	authors	even	recommend	the	
melatonine	application	in	cancer	therapy	[35,	36].	
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ЦИРКАДИАННЫЕ РИТМЫ ЦИТОТОКСИЧЕСКОЙ АКТИВНОСТИ 
МОНОНУКЛЕАРНЫХ КЛЕТОК ПЕРИФЕРИЧЕСКОЙ КРОВИ 
БОЛЬНЫХ ЗЛОКАЧЕСТВЕННОЙ МЕЛАНОМОЙ 
Цель: изучить циркадианные ритмы (ЦР) цитотоксической активности мононуклеарных клеток периферической кро-
ви (МКПК) больных злокачественной меланомой по сравнению с таковыми здоровых доноров. Методы: активность 
НК-клеток и МКПК, выделенных из крови 5 больных со злокачественной меланомой I и II стадий и 12 здоровых доноров, 
оценивали при помощи радиоиммунного метода и  NBT-теста. Результаты: установлено, что у онкологических больных 
нарушена нормальная циркадианная ритмичность активности НК-клеток и МКПК, причем степень выраженности таких 
нарушений возрастает параллельно с прогрессией заболевания. К наиболее типичным изменениям относятся дискоорди-
нация между цитотоксическими ритмами НК-клеток и мононуклеарными фагоцитами (синхронизированными у здоровых 
доноров) и изменения основных параметров ритма: сдвиг фаз и смещения амплитуды. Выводы: у больных меланомой выяв-
лены значительные изменения ЦР НК-клеток и МКПК, причем степень нарушения ритма зависит от стадии заболевания. 
Во всех изученных случаях выявлены изменения фаз и амплитуды ЦР,  декоординация ритмов  НК-клеток и  МКПК.
Ключевые слова: злокачественная меланома, циркадианный ритм, активность НК-клеток, цитотоксическая активность 
мононуклеарных клеток. 
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